Netherlands for Biotech / Life Sciences

Netherlands ranks #14 of 25 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 57/100. The top strengths for Biotech / Life Sciences founders are funding access and startup ecosystem. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

Netherlands applies a statutory corporate tax rate of 25.8%, and an IP box regime at 9% for qualifying IP income. The jurisdiction has 100 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Netherlands is a premier European biotech jurisdiction. EMA (European Medicines Agency) is headquartered in Amsterdam. Yes!Delft and Leiden Bio Science Park are world-class biotech clusters. Clinical trials benefit from excellent hospital networks. WBSO applies to biotech R&D. Strong patent protection via Dutch and EU patent offices. Netherlands offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

Netherlands ranks #14 for Biotech / Life Sciences with 57/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by remote infrastructure, where Netherlands is weaker. Use NomadSignal's comparison pages to evaluate Netherlands head-to-head against specific alternatives.